Oligodendrocyte Genesis after Spinal Cord Injury
Oligodendrocyte Genesis after Spinal Cord Injury
批准号:
7994743
负责人:
DANA M MCTIGUE
金额:
$32.95万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-01-05 至 2013-12-31
关键词:
AdultAstrocytesAttentionAxonCSPG4 geneCell ProliferationCellsCentral Nervous System DiseasesCessation of lifeChemicalsChronicCiliary Neurotrophic FactorCiliary Neurotrophic Factor ReceptorComplementComplexContusionsDataDemyelinationsEnvironmentEvaluationExhibitsFibroblast Growth Factor 2Functional disorderGoalsHealthHumanImmunofluorescence ImmunologicInflammatoryInjuryLabelLentivirus VectorLesionLightLinkLocomotor RecoveryMediatingMethodsMicroscopicMitoticModelingMyelinNatureNecrosisOligodendrogliaPathologyPlant ResinsPopulationProductionRecoveryRecovery of FunctionRegulationReplacement TherapyResolutionRodentRoleSignal PathwaySignaling MoleculeSiteSmall Interfering RNASpinalSpinal CordSpinal RemyelinationSpinal cord injuryStem cellsTechniquesTechnologyTestingTherapeuticTissuesTransplantationUp-RegulationViralbasecell typeclinically relevantdesignfollow-upfunctional lossgliogenesisinjuredinsightmyelinationnovelprogenitorrepairedresponsestem
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Protracted oligodendrocyte (OL) death occurs after spinal cord injury (SCI). Because these cells myelinate axons, their loss leads to axon dysfunction and contributes to functional loss after SCI. Although many studies have characterized OL death after SCI, few have examined whether endogenous OL replacement occurs. We recently noted that a large number of new OLs are generated in the rim of tissue surrounding the lesion cavity after SCI. In the current proposal, these exciting findings will be followed up by determining if these new OLs contribute to axon remyelination and examining the mechanisms involved in their formation. Specifically, we will test the hypothesis that OL genesis in the traumatically injured adult spinal cord leads to remyelination of spinal axons and is dependent on astrocyte-derived CNTF. In Aim 1, we will expand upon preliminary data by characterizing the spatio-temporal extent of OL remyelination after SCI. Because only newly generated OLs can remyelinate axons, this data will provide information on the extent that the new cells contribute to endogenous repair. To complement this data, we will use GFP-retroviral lineage tracing to examine the fate of dividing cells after injury and to fluorescently label newly derived OLs and myelin ensheathing axons. These studies will be followed up in Aim 2 by examining the extent to which new OL genesis and OL remyelination depend on the presence of CNTF after SCI. Lentiviral-siRNA technology will be used to silence CNTF expression and spinal cords will be examined for changes in oligodendrocyte progenitor proliferation, new OL formation and myelination. Based on our pilot data, we predict that the number of OLs along lesion borders will be significantly reduced thereby leading to a decrease in remyelination of spinal axons. We will also examine the functional consequences of the absence of CNTF and reduction on oligogenesis. In Aim 3, we will examine the mechanisms of action for CNTF-mediated effects, including evaluating cellular expression of CNTF receptors and intracellular signaling molecules. Since CNTF is known to stimulate FGF-2 production and we and others show that FGF-2 is upregulated after SCI, we will also evaluate whether CNTF is essential for post-SCI FGF-2 expression. Collectively, the data generated will provide novel information on regulation of new OL formation in the injured adult CNS and the ability of these cells to help repair the damage induced by traumatic SCI. PUBLIC HEALTH RELEVANCE The relevance of this proposal is that the data will shed light on how new cells are formed after injury to the spinal cord and whether the new cells can help repair the damage. By understanding what controls the new cell formation, we will gain an understanding of what the cells are capable of doing and how to manipulate the injury site to enhance their reparative abilities.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Spinal cord injury causes liver pathology and metabolic dysfunction
-
批准号:10589087
-
项目类别:
-
资助金额:$53.75万
-
财政年份:2021
-
负责人:DANA M MCTIGUE
-
依托单位:
Spinal cord injury causes liver pathology and metabolic dysfunction
-
批准号:10210615
-
项目类别:
-
资助金额:$53.99万
-
财政年份:2021
-
负责人:DANA M MCTIGUE
-
依托单位:
Spinal cord injury causes liver pathology and metabolic dysfunction
-
批准号:10377530
-
项目类别:
-
资助金额:$53.75万
-
财政年份:2021
-
负责人:DANA M MCTIGUE
-
依托单位:
Regulation of myelination after spinal cord injury
-
批准号:10187660
-
项目类别:
-
资助金额:$43.61万
-
财政年份:2018
-
负责人:DANA M MCTIGUE
-
依托单位:
Regulation of myelination after spinal cord injury
-
批准号:10412019
-
项目类别:
-
资助金额:$43.07万
-
财政年份:2018
-
负责人:DANA M MCTIGUE
-
依托单位:
Ohio State University Neuroscience Center Core-Core B
-
批准号:10005507
-
项目类别:
-
资助金额:$12.51万
-
财政年份:2017
-
负责人:DANA M MCTIGUE
-
依托单位:
Restoring Iron Homeostasis to Promote Recovery after Spinal Cord Injury
-
批准号:8703831
-
项目类别:
-
资助金额:$35.69万
-
财政年份:2013
-
负责人:DANA M MCTIGUE
-
依托单位:
Restoring Iron Homeostasis to Promote Recovery after Spinal Cord Injury
-
批准号:8599191
-
项目类别:
-
资助金额:$35.94万
-
财政年份:2013
-
负责人:DANA M MCTIGUE
-
依托单位:
Restoring Iron Homeostasis to Promote Recovery after Spinal Cord Injury
-
批准号:8893177
-
项目类别:
-
资助金额:$36.05万
-
财政年份:2013
-
负责人:DANA M MCTIGUE
-
依托单位:
Oligodendrocyte Genesis after Spinal Cord Injury
-
批准号:8386663
-
项目类别:
-
资助金额:$31.03万
-
财政年份:2009
-
负责人:DANA M MCTIGUE
-
依托单位:
Oligodendrocyte Genesis after Spinal Cord Injury
-
批准号:8019307
-
项目类别:
-
资助金额:$2.73万
-
财政年份:2009
-
负责人:DANA M MCTIGUE
-
依托单位:
Oligodendrocyte Genesis after Spinal Cord Injury
-
批准号:7580292
-
项目类别:
-
资助金额:$33.58万
-
财政年份:2009
-
负责人:DANA M MCTIGUE
-
依托单位:
Oligodendrocyte Genesis after Spinal Cord Injury
-
批准号:8197781
-
项目类别:
-
资助金额:$32.16万
-
财政年份:2009
-
负责人:DANA M MCTIGUE
-
依托单位:
Oligodendrocyte Genesis after Spinal Cord Injury
-
批准号:7754669
-
项目类别:
-
资助金额:$33.27万
-
财政年份:2009
-
负责人:DANA M MCTIGUE
-
依托单位:
FORE-SCI TRAINING PROGRAM (RFP 08-01)
-
批准号:7952541
-
项目类别:
-
资助金额:$114.55万
-
财政年份:2008
-
负责人:DANA M MCTIGUE
-
依托单位:
Axons and the Extracellular Matrix in Spinal Cord Injury
-
批准号:8870445
-
项目类别:
-
资助金额:$33.14万
-
财政年份:2004
-
负责人:DANA M MCTIGUE
-
依托单位:
Ohio State Neuroscience Center Core
-
批准号:8211341
-
项目类别:
-
资助金额:$10.78万
-
财政年份:2004
-
负责人:DANA M MCTIGUE
-
依托单位:
Ohio State Neuroscience Center Core
-
批准号:8374602
-
项目类别:
-
资助金额:$10.65万
-
财政年份:2004
-
负责人:DANA M MCTIGUE
-
依托单位:
Axons and the Extracellular Matrix in Spinal Cord Injury
-
批准号:8686967
-
项目类别:
-
资助金额:$32.81万
-
财政年份:2004
-
负责人:DANA M MCTIGUE
-
依托单位:
Ohio State Neuroscience Center Core
-
批准号:8484355
-
项目类别:
-
资助金额:$10.14万
-
财政年份:2004
-
负责人:DANA M MCTIGUE
-
依托单位:
国内基金
海外基金
Ascl1介导Wnt/beta-catenin通路在TLE海马硬化中反应性Astrocytes异常增生的作用及调控机制
-
批准号:31760279
-
项目类别:地区科学基金项目
-
资助金额:35.0万元
-
批准年份:2017
-
负责人:丁银秀
-
依托单位: